132 related articles for article (PubMed ID: 31495596)
1. Surveillance of invasive meningococcal disease in the Tel Aviv District, Israel, 2007-2017.
Salama M; Kopel E; Jaffe J; Amitai Z; Sheffer R; Rahmani S; Yuabov I; Dardik L; Valinsky L
Vaccine; 2019 Sep; 37(42):6186-6191. PubMed ID: 31495596
[TBL] [Abstract][Full Text] [Related]
2. Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines.
Stein-Zamir C; Shoob H; Abramson N; Block C; Keller N; Jaffe J; Valinsky L
Hum Vaccin Immunother; 2019; 15(1):242-248. PubMed ID: 30156954
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014.
Whittaker R; Dias JG; Ramliden M; Ködmön C; Economopoulou A; Beer N; Pastore Celentano L;
Vaccine; 2017 Apr; 35(16):2034-2041. PubMed ID: 28314560
[TBL] [Abstract][Full Text] [Related]
4. Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006-2014.
Stefanelli P; Fazio C; Neri A; Boros S; Renna G; Pompa MG;
Vaccine; 2015 Jul; 33(31):3678-81. PubMed ID: 26087297
[TBL] [Abstract][Full Text] [Related]
5. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: priority populations for vaccination.
Archer BN; Chiu CK; Jayasinghe SH; Richmond PC; McVernon J; Lahra MM; Andrews RM; McIntyre PB;
Med J Aust; 2017 Nov; 207(9):382-387. PubMed ID: 29092704
[TBL] [Abstract][Full Text] [Related]
7. Invasive meningococcal disease in children in Jerusalem.
Stein-Zamir C; Abramson N; Zentner G; Shoob H; Valinsky L; Block C
Epidemiol Infect; 2008 Jun; 136(6):782-9. PubMed ID: 17662169
[TBL] [Abstract][Full Text] [Related]
8. Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.
Stoof SP; Rodenburg GD; Knol MJ; Rümke LW; Bovenkerk S; Berbers GA; Spanjaard L; van der Ende A; Sanders EA
Clin Infect Dis; 2015 Oct; 61(8):1281-92. PubMed ID: 26123933
[TBL] [Abstract][Full Text] [Related]
9. Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987-2013.
Husain EH; Barakat M; Al-Saleh M
J Infect Public Health; 2015; 8(5):441-7. PubMed ID: 25779346
[TBL] [Abstract][Full Text] [Related]
10. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
Krizova P; Musilek M
Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.
Pezzotti P; Miglietta A; Neri A; Fazio C; Vacca P; Voller F; Rezza G; Stefanelli P
Vaccine; 2018 Jul; 36(29):4222-4227. PubMed ID: 29895504
[TBL] [Abstract][Full Text] [Related]
12. Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016.
Rodrigues CMC; Lucidarme J; Borrow R; Smith A; Cameron JC; Moxon ER; Maiden MCJ
Emerg Infect Dis; 2018 Apr; 24(4):673-682. PubMed ID: 29553330
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of childhood invasive meningococcal disease in Israel during a 22-year period (1989-2010).
Ben-Shimol S; Dagan R; Schonmann Y; Givon-Lavi N; Keller N; Block C; Kassis I; Ephros M; Greenberg D
Infection; 2013 Aug; 41(4):791-8. PubMed ID: 23475472
[TBL] [Abstract][Full Text] [Related]
14. Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
Hong E; Giuliani MM; Deghmane AE; Comanducci M; Brunelli B; Dull P; Pizza M; Taha MK
Vaccine; 2013 Feb; 31(7):1113-6. PubMed ID: 23261039
[TBL] [Abstract][Full Text] [Related]
15. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
[No Abstract] [Full Text] [Related]
16. The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines.
Pelton SI
J Adolesc Health; 2016 Aug; 59(2 Suppl):S3-S11. PubMed ID: 27449148
[TBL] [Abstract][Full Text] [Related]
17. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.
Poland GA
Clin Infect Dis; 2010 Mar; 50 Suppl 2():S45-53. PubMed ID: 20144016
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of two decades of invasive meningococcal disease in the Republic of Ireland: an analysis of national surveillance data on laboratory-confirmed cases from 1996 to 2016.
Bennett D; O'Lorcain P; Morgan S; Cotter S; Cafferkey M; Cunney R
Epidemiol Infect; 2019 Jan; 147():e142. PubMed ID: 30869045
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
Noronha CP; Struchiner CJ; Halloran ME
Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of invasive meningococcal disease in Austria 2010.
Steindl G; Liu YL; Schmid D; Orendi U; Kormann-Klement A; Heuberger S
Wien Klin Wochenschr; 2011 Oct; 123 Suppl 1():10-4. PubMed ID: 21935643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
